KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,463,546 | -22.1% | 339,840 | -0.0% | 1.03% | -17.1% |
| Q2 2023 | $73,722,061 | +19.4% | 339,968 | +0.0% | 1.25% | +10.0% |
| Q1 2023 | $61,739,073 | -39.5% | 339,898 | -34.6% | 1.13% | -43.7% |
| Q4 2022 | $102,121,050 | -12.6% | 519,700 | 0.0% | 2.01% | -12.4% |
| Q3 2022 | $116,896,000 | +49.2% | 519,700 | -16.1% | 2.30% | +37.2% |
| Q2 2022 | $78,360,000 | -17.4% | 619,400 | -17.2% | 1.68% | +12.8% |
| Q1 2022 | $94,839,000 | -3.2% | 748,000 | 0.0% | 1.49% | +18.7% |
| Q4 2021 | $97,988,000 | +7.1% | 748,000 | 0.0% | 1.25% | +3.7% |
| Q3 2021 | $91,503,000 | +7.3% | 748,000 | 0.0% | 1.21% | +5.4% |
| Q2 2021 | $85,265,000 | -27.0% | 748,000 | -23.0% | 1.14% | -33.8% |
| Q1 2021 | $116,753,000 | +27.5% | 971,077 | +7.8% | 1.73% | +23.2% |
| Q4 2020 | $91,540,000 | +31.4% | 901,077 | 0.0% | 1.40% | +2.9% |
| Q3 2020 | $69,671,000 | -30.6% | 901,077 | 0.0% | 1.36% | -37.5% |
| Q2 2020 | $100,434,000 | +54.8% | 901,077 | 0.0% | 2.18% | +3.9% |
| Q1 2020 | $64,878,000 | +300.8% | 901,077 | +319.4% | 2.10% | +360.7% |
| Q4 2019 | $16,186,000 | +235.0% | 214,843 | -27.4% | 0.46% | +185.0% |
| Q3 2019 | $4,831,000 | -78.1% | 296,000 | -73.9% | 0.16% | -76.2% |
| Q2 2019 | $22,060,000 | – | 1,136,234 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |